TD Waterhouse Canada’s AngioDynamics ANGO Stock Holding History

TD Waterhouse Canada’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.82K	Buy	+750	New	+$8.54K	﹤0.01%	1828

Other funds holding ANGO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BAM

Bastion Asset Management Montreal, Canada $295M AUM 19.08% 1-Year Est. Return

Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return

PFC

Phocas Financial Corp Alameda, California $721M AUM 63.77% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

WPC

White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

TD Waterhouse Canada's ANGO Position: Q2 2026 in Review

TD Waterhouse Canada opened a new position in AngioDynamics (ANGO) in Q2 2026: 750 shares worth $9.82K. The stake represents ﹤0.01% of the portfolio and ranks #1828 among its holdings.

58 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

TD Waterhouse Canada held 750 shares of AngioDynamics worth $9.82K as of Q2 2026.
AngioDynamics was a new TD Waterhouse Canada position in Q2 2026.
AngioDynamics made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #1828 holding.
58 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.